"/> Invitrogen™ Peptide synthétique TEM7 humain | B-LABO France

Invitrogen™ Peptide synthétique TEM7 humain

Réf. : BL-RE-175956Réf. fabricant : 15358680 50 μg
137,00 € HT

Synthetic Peptide

Gene ID (Entrez)
57125
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
Q8IUK5
Nom usuel
Human TEM7
Marque
Invitrogen

TEM7 Synthetic Peptide, PEP-0544, from Invitrogen.

Recently, using SAGE (Serial Analysis of Gene Expression) technology, St. Croix et al, have identified 46 genes, whose expression is specifically elevated in tumor-associated endothelium. Nine of these genes were prominently expressed only in tumor endothelial cells (EC), but were absent or barely detectable in normal ECs, and named as Tumor Endothelial Markers (TEMs, TEM 1-9). TEM7 (Tumor endothelial marker 7) transcripts are specifically expressed in the endothelium of colorectal cancer, primary cancers of lung, pancreas, breast, and brain. TEM7 is expressed specifically in endothelium of these cancers, whether primary or metastasis. The other six members of this family (TEM1, 3, 4, 5, 8, and 9) also show similar expression pattern in lung and brain tumors, and liver metastasis. Since most of the genes expressed differentially in tumor endothelium are also expressed during angiogenesis, these newly discovered genes might provide important resources for basic and clinical studies of human angiogenesis.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-175956
Réf. fabricant15358680
Gene ID (Entrez)57125
EspècesHuman
Méthode de purificationpurified
Numéro d’adhésionQ8IUK5
Nom usuelHuman TEM7
Concentration200 μg/mL
Contenu et stockage-20°C
FormatLiquid
FormulePBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application)Blocking Assay, Control
Symbole de gène(s)PLXDC1
LyophiliséNo
Conservateur0.02% sodium azide
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
Tampon de stockagePBS
Une question, une configuration particulière ?
Contactez-nous pour un devis.